Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey
Patient Experiences With Prescription Cannabinoids in Germany: Protocol for a Mixed Methods, Exploratory, and Anonymous Web-Based Survey
Jan Moritz Fischer
1
, MPH, MD ;
Farid-Ihab Kandil
1
, Dr rer nat ;
Matthias Karst
2
, Prof Dr med ;
Laura Sophie Zager
1
, BSc ;
Michael Jeitler
1
, Dr med ;
Felix Kugler
1
;
Franziska Fitzner
2
, MD ;
Andreas Michalsen
1, 3
, Prof Dr med ;
Christian S Kessler
1, 3
, PD, Dr med, MA, MSc
1
Institute of Social Medicine, Epidemiology and Health Economics, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
2
Department of Anesthesiology and Intensive Care Medicine, Pain Clinic, Hannover Medical School, Hannover, Germany
3
Department of Internal and Integrative Medicine, Immanuel Hospital Berlin, Berlin, Germany
Corresponding Author:
-
Jan Moritz Fischer, MPH, MD
-
Institute of Social Medicine, Epidemiology and Health Economics
-
Charité – Universitätsmedizin Berlin
-
corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin
-
Department of Internal and Integrative Medicine, Immanuel Hospital
-
Am Kleinen Wannsee 5D
-
Berlin, 14109
-
Germany
-
Phone:
49 30 80505 691
-
Email: jan-moritz.fischer@charite.de